October 23, 2024

Pfizer Layoffs Hit 75 Jobs in Sanford Following DMD Trial Setback

Pfizer has laid off 75 employees at its Sanford, North Carolina, facility, marking the second round of workforce reductions in connection to its…

Biotech /

October 22, 2024

AvenCell Raises $112 Million in Series B Funding Led by Novo Holdings

AvenCell Therapeutics, Inc., a clinical-stage cell therapy company specializing in innovative CAR-T cell therapies, has announced the successful completion of a $112 million…

Biotech /

October 15, 2024

Alchemy Secures $31M Seed Funding to Expand In-House Pharmacy Solutions for HIV and HCV Clinics

Alchemy, a provider of in-house pharmacy programs, has raised $31 million in seed financing, led by Andreessen Horowitz (a16z) Bio + Health, with…

Biotech / Healthcare /

October 9, 2024

ShiraTronics Raises $66M in Series B Funding to Advance Neurostimulation Therapy for Chronic Migraines

ShiraTronics, a medical device company developing neurostimulation therapies for chronic migraine patients, has closed a $66 million Series B financing round. The investment…

Biotech /

October 8, 2024

Maven Clinic Raises $125M Series F to Expand Global Virtual Health Platform for Women and Families

Maven Clinic, the world’s largest virtual clinic for women’s and family health, has secured $125 million in Series F funding, led by StepStone…

Biotech / Healthcare /

October 7, 2024

ProductLife Group Acquires Swiss Pharmacometrics Firm IntiQuan to Expand Drug Development Services

ProductLife Group (PLG), a global leader in regulatory, scientific, compliance, and digital transformation consulting services for the life sciences sector, has announced its…

Biotech /

October 7, 2024

CVS Health Lays Off 3,000 Employees Amid Industry Challenges and Restructuring

CVS Health has announced plans to lay off nearly 3,000 employees in 2024, representing about 1% of its overall workforce. These layoffs primarily…

Biotech /

October 2, 2024

Triveni Bio Raises $115M Series B Financing to Advance Antibody Treatments for I&I Disorders

Triveni Bio Inc., a cutting-edge biotech company developing novel antibody treatments for immune and inflammatory (I&I) disorders, announced the successful closure of a…

Biotech /

October 1, 2024

Shattuck Labs Layoffs Hit 40% of Staff as CD47 Program Is Dropped Following Weak Efficacy Data

Shattuck Labs has terminated its CD47 program after weak efficacy data from its lead candidate, SL-172154, in blood cancer trials. The biotech reported…

Biotech / Healthcare /

October 1, 2024

Nym Raises $47 Million Growth Investment to Expand Autonomous Medical Coding Capabilities

Nym, a pioneer in autonomous medical coding, has announced a $47 million growth investment led by PSG, with participation from Google Ventures, Addition,…

Biotech /

Get Silicon Valley Top 1000 Contacts List

October 23, 2024

Pfizer Layoffs Hit 75 Jobs in Sanford Following DMD Trial Setback

October 22, 2024

AvenCell Raises $112 Million in Series B Funding Led by Novo Holdings

October 15, 2024

Alchemy Secures $31M Seed Funding to Expand In-House Pharmacy Solutions for HIV and HCV Clinics

October 9, 2024

ShiraTronics Raises $66M in Series B Funding to Advance Neurostimulation Therapy for Chronic Migraines

October 8, 2024

Maven Clinic Raises $125M Series F to Expand Global Virtual Health Platform for Women and Families

October 7, 2024

ProductLife Group Acquires Swiss Pharmacometrics Firm IntiQuan to Expand Drug Development Services

October 7, 2024

CVS Health Lays Off 3,000 Employees Amid Industry Challenges and Restructuring

October 2, 2024

Triveni Bio Raises $115M Series B Financing to Advance Antibody Treatments for I&I Disorders

October 1, 2024

Shattuck Labs Layoffs Hit 40% of Staff as CD47 Program Is Dropped Following Weak Efficacy Data

October 1, 2024

Nym Raises $47 Million Growth Investment to Expand Autonomous Medical Coding Capabilities

Follow Silicon Valley Journals

Awarded by

Fundings

Quick links

Company